Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

SmithRx Stock

Q: How to sell SmithRx stock?

If you hold private company shares of SmithRx - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your SmithRx stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

www.smithrx.comHealthcare / Digital HealthFounded: 2016

With a focus on finding a better way to manage employee pharmacy benefits, SmithRx is a pharmacy benefit management (PBM) company that aims to use technology to connect employers and health plan members to specialized programs for pharmaceutical coverage. It provides a platform for small businesses so they can gain transparency and alternative methods to deliver pharmacy benefits. As a result, SmithRX strives to enable employees to access medications that are affordable and easy to acquire while also trying to reduce overhead costs for employers. SmithRx was was founded by Jake Frenz in 2016 and is headquartered in San Francisco, CA.

Buy or sell SmithRx stockLearn more about SmithRx IPO

OverviewFinancingsValuation

Enterprise Value

Access SmithRx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SmithRx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

SmithRx investors also invested in these private companies

Venrock

Element Biosciences, Dataminr, Devoted Health, Rebellion Defense, Aledade, Mashgin, Included Health, ABL Space Systems, Cloudflare, Astronomer

BoxGroup

Upside Foods, Ro, Novo, Harry's, Maven, Forward, Alma, Titan, Hex, Arcadia

Founders Fund

Neuralink, Anduril, Crusoe, Scale AI, Ripple, Flock Safety, Stripe, Wave, The Boring Company, Cognition

Great Oaks Venture Capital

Strava, Course Hero, Maven, Affinity, Hungryroot, SingleStore (MemSQL), Workrise, SmithRx, Moov Technologies, Vise

Blumberg Capital

SmithRx, Fundbox, FundGuard, Yotpo, SQream Technologies, Zanbato

Catapult VC

Rappi, Carrot, Hint, Philo, Mashgin, Collective Health, Qumulo, Deepgram, SmithRx, CareRev

FourCities Capital

Carrot, Mashgin, Deepgram, SmithRx, Kettle, RapidSOS

NextGen Venture Partners

SmithRx, Hone, Kasa Living

Metaplanet Holdings

Anthropic, CoinList, BillionToOne, Loyal, Fabric Cryptography, SmithRx, Unlikely AI, OpenTrons, Nanotronics, Improbable

SciFi VC

PsiQ, Brex, Virta Health, Synthego, Clipboard Health, SmithRx, Mixpanel, AgentSync, Color, Traba

Precursor Ventures

Rad AI, Carrot, Juniper Square, Origin Financial, Clipboard Health, Superhuman, SmithRx, Pair Eyewear, Anyroad

Presight Capital

SmithRx, Razor Group, Alto Neuroscience, Peek Travel, Unmind, Commons

MCVC Partners

SmithRx

W Ventures

Scale AI, Captions, Tempus, Gusto, X-energy, Taptap Send, Zum, Common, Tala, AliveCor

Highbury Group

SmithRx

Team

Management Team

Jacob Frenz

Founder & Chief Executive Officer

Board Members

Bryan Roberts Ph.D

Venrock

SmithRx stock FAQs

Can you buy SmithRx stock?

As SmithRx is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like SmithRx, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy SmithRx stock?

To invest in a private company like SmithRx through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell SmithRx stock?

Yes, you may be able to sell your SmithRx stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell SmithRx stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your SmithRx stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is SmithRx a public company?

No, SmithRx is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is SmithRx’s stock price?

SmithRx is a privately held company and therefore does not have a public stock price. However, you may access SmithRx’s private market stock price with Forge Data.

What is SmithRx’s stock ticker symbol?

SmithRx does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Business Wire 01/23/2024

SmithRx Continues to Fix Broken Pharmacy Benefits Management System, Closes $60M in Series C Funding Led by Venrock

SmithRx, a next-generation pharmacy benefits management (PBM) company, closed a $60M Series C financing round — building on the company’s $20M Series B round raised in 2022. Led by top Silicon Valley healthcare venture capital firm Venrock, the latest funding positions SmithRx to continue reducing costs of pharmacy benefits for small and midsize self-insured businesses.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.